Table 5 Clinical and genetic data of carefully selected neuroblastoma samples that were included in this study
Sample number | Lab number | % Tumor cells | Stage | MYCN amp | Ploidy | Adrenal localisation | Age | Dead/alive | Overall survival (months) | Type |
|---|---|---|---|---|---|---|---|---|---|---|
NB1 | 01T15 | 80 | 4S | No | Tri | Yes | < 1 year | Alive | 61.4 | Favorable |
NB2 | 98T33 | 95 | 1 | No | Tri | Yes | < 1 year | Alive | 76.9 | Favorable |
NB3 | 96T82 | 90 | 1 | No | Tri | Yes | < 1 year | Alive | 115.5 | Favorable |
NB4 | 99T129 | 90 | 1 | No | Tri | Yes | < 1 year | Alive | 71.7 | Favorable |
NB5 | 01T28 | 90 | 4 | Yes | Di | Yes | > 1 year | Dead | 5.6 | Unfavorable |
NB6 | 03T304 | 100 | 3a | No | Di | Abdominal | > 1 year | Alive | 12.0 | Unfavorable |
NB7 | 03T236 | 90 | 4 | No | ND | Yes | > 5 year | Dead | 19.4 | Unfavorable |
NB8 | 00T54 | 70 | 1 | No | Tri | Yes | < 1 year | Alive | 62.6 | Favorable |
NB9 | 00T35 | > 95 | 4 | Yes | Di | Yes | < 1 year | Dead | 13.7 | Unfavorable |
NB10 | 99T125 | 80 | 3 | No | Di | Yes | > 5 year | Alive | 79.3 | Unfavorable |
NB11 | 92W145 | 70 | 4 | No | ND | ND | > 5 year | Dead | 19.5 | Unfavorable |
NB12 | 02T192 | 100 | 4 | Yes | Di | Abdominal | > 5 year | Dead | 16.2 | Unfavorable |
NB13 | D031 | > 95 | 4 | No | Di | Abdominal | > 1 year | Dead | 64.8 | Unfavorable |
NB14 | E002 | > 80 | 4 | No | ND | Abdominal | > 1 year | Alive | 65.7 | Unfavorable |
NB15 | E037 | > 80 | 4 | No | ND | Abdominal | > 1 year | Alive | 45.3 | Unfavorable |
NB16 | E044 | > 80 | 4 | No | ND | Yes | < 1 year | Alive | 37.0 | Unfavorable |
NB17 | E121 | > 80 | 4 | Yes | ND | Abdominal | > 1 year | Dead | 78.4 | Unfavorable |
NB18 | 04T121 | 60 | 3 | Yes | Di | Yes | > 1 year | Dead | 6 | Unfavorable |